Niranjan Kanesa-thasan, Chief Medical Officer at Icosavax, Inc. (ICVX), sold 3,323 shares at $8.86 ($29K) on 2023-07-31, disclosed to the SEC on 2023-08-01.
Scheduled sale ($29k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ICVX | SELL | 2023-02-15 | $19K | — | Filing → |
| ICVX | SELL | 2022-08-02 | $22K | — | Filing → |
| ICVX | BUY | 2021-08-02 | $100K | — | Filing → |